Brief: Hydration Pharmaceuticals Announces Q4 FY23 Net Sales Of US$2.11 Mln

Hydration Pharmaceuticals

31/01/2024 04:35

Jan 31 (Reuters) - Hydration Pharmaceuticals Co Ltd
 HPC.AX :
    * Q4 FY23 NET SALES OF US$2.11M, SLIGHT DECREASE ON LAST
QUARTER
    * Q4 NET OPERATING EXPENDITURE DOWN 56% ON PCP TO $1.14
MILLION
    * GROSS PROFIT UP 4% TO US$1.26M IN Q4 FY23
    * TEMPORARY OUT OF STOCKS DURING QUARTER LED TO ESTIMATED
UNFULFILLED ORDERS OF US$0.6M
    * EXPECTS SWIFT RECOVERY FROM TEMPORARY ISSUE, HAS GOT
SEVERAL
SHIPMENTS TO IMPROVE SITUATION
    * HYDRATION PHARMACEUTICALS SEES ADDITIONAL SALES FROM NEW
SHIPMENTS DURING CURRENT QUARTER

Source text for Eikon:  ID:nASXZndYs 
Further company coverage:  HPC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))